- Research works
- 84 ▲ 1267% vs 2013–17
- Citations
- 217 2.6 per fractional work
- Top-10% rate
- 7.3% record average 16.5%
- Open access
- 55% world 28%
Not ranked overall: Instituto Químico Biológico is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Economics, Econometrics and Finance, 6.0×. Every wedge is a field page.
- Economics, Econometrics and Finance 6.0×
- Mathematics 5.4×
- Immunology and Microbiology 3.4×
- Health Professions 2.7×
- Medicine 2.6×
- Pharmacology, Toxicology and Pharmaceutics 2.4×
- Biochemistry, Genetics and Molecular Biology 1.4×
- Psychology 0.8×
- Decision Sciences 0.6×
- Computer Science 0.5×
- Dentistry 0.4×
- Nursing 0.4×
- Arts and Humanities 0.3×
- Neuroscience 0.2×
- Social Sciences 0.2×
- Energy 0.1×
- Environmental Science 0.1×
- Business, Management and Accounting 0.0×
- Engineering 0.0×
Which keywords describe research at Instituto Químico Biológico?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Quality of Life, Economic Evaluation, Cost-effectiveness Analysis, Health Utility Measures, Epidemiology, Clinical Trials, Guidelines and Precision Medicine.
- Telemedicine
- Health Outcomes
- Bayesian Methods
- Anticoagulant Therapy
- Genetics
- Type 2 Diabetes
- Off-Label Drug Use
- Chemotherapy
- Inflammation
- Public Health
- Medication Adherence
- Biomarkers
- Generic Drugs
- Drug Development Costs
- Immunotherapy
- Precision Medicine
- COVID-19
- Clinical Trials
- Cost-effectiveness Analysis
- Quality of Life
- Epidemiology
- Economic Evaluation
- Health Utility Measures
- Healthcare
- Guidelines
- Pharmaceutical Industry
- Targeted Therapy
- Electronic Health Records
- Predictive Modeling
- Clinical Event Prediction
- Patient Similarity
- Treatment
- Adverse Drug Reactions
- Clinical Guidelines
- Pediatric Pharmacokinetics
- Cancer Genomics
- Mutational Signatures
- Atrial Fibrillation
- Glycemic Control
- Insulin Therapy
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology5▲ 2.7×26 topics
- Quality of Life5▲ 7.3×10 topics
- Economic Evaluation3▲ 59×2 topics
- Cost-effectiveness Analysis3▲ 82×1 topic
- Health Utility Measures3▲ 82×1 topic
- Clinical Trials3▲ 8.3×8 topics
- Healthcare2▲ 4.5×5 topics
- COVID-192▲ 3.3×9 topics
- Guidelines2▲ 9.8×6 topics
- Precision Medicine2▲ 9.8×5 topics
- Pharmaceutical Industry2▲ 116×2 topics
- Immunotherapy2▲ 5.3×8 topics
- Targeted Therapy2▲ 18×3 topics
- Drug Development Costs2▲ 139×1 topic
- Electronic Health Records2▲ 41×2 topics
- Generic Drugs2▲ 139×1 topic
- Predictive Modeling2▲ 13×2 topics
- Biomarkers2▲ 5.0×7 topics
- Clinical Event Prediction2▲ 62×1 topic
- Medication Adherence2▲ 64×2 topics
- Patient Similarity2▲ 62×1 topic
- Public Health2▲ 2.3×7 topics
- Treatment2▲ 2.9×10 topics
- Inflammation2▲ 1.59×9 topics
- Adverse Drug Reactions1▲ 58×2 topics
- Chemotherapy1▲ 4.3×11 topics
- Clinical Guidelines1▲ 10×5 topics
- Off-Label Drug Use1▲ 110×1 topic
- Pediatric Pharmacokinetics1▲ 110×1 topic
- Type 2 Diabetes1▲ 13×4 topics
- Cancer Genomics1▲ 38×1 topic
- Genetics1▲ 4.0×7 topics
- Mutational Signatures1▲ 38×1 topic
- Anticoagulant Therapy1▲ 21×1 topic
- Atrial Fibrillation1▲ 27×1 topic
- Bayesian Methods1▲ 51×2 topics
- Glycemic Control1▲ 16×4 topics
- Health Outcomes1▲ 9.8×4 topics
- Insulin Therapy1▲ 20×3 topics
- Telemedicine1▲ 17×2 topics
Which research topics does Instituto Químico Biológico publish most on?
By volume in 2022–2025: Health Systems, Economic Evaluations, Quality of Life, Pharmaceutical Economics and Policy, Machine Learning in Healthcare and Pharmaceutical studies and practices.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 3 works
- 2 Pharmaceutical Economics and Policy Economics and Econometrics 2 works
- 3 Machine Learning in Healthcare Artificial Intelligence 2 works
- 4 Pharmaceutical studies and practices Pediatrics, Perinatology and Child Health 1 works
- 5 Cancer Genomics and Diagnostics Cancer Research 1 works
- 6 Atrial Fibrillation Management and Outcomes Cardiology and Cardiovascular Medicine 1 works
- 7 Statistical Methods in Clinical Trials Statistics and Probability 1 works
- 8 Biosimilars and Bioanalytical Methods Immunology 1 works
- 9 Advanced Causal Inference Techniques Statistics and Probability 1 works
- 10 Telemedicine and Telehealth Implementation Public Health, Environmental and Occupational Health 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Instituto Químico Biológico's research output changed?
Output in 2018–2022 was 1267% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Madrid
- Universidad Complutense de Madrid
- Universidad Autónoma de Madrid
- Universidad Politécnica de Madrid
- Consejo Superior de Investigaciones Científicas
- Universidad Carlos III de Madrid
- Universidad Rey Juan Carlos
- Universidad Nacional de Educación a Distancia
- Hospital Universitario La Paz
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.